Clinical Trial Update: Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessed the efficacy and safety of IPI-504 (retaspimycin) with trastuzumab in locally advanced or metastatic HER2-positive breast cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IPI-504 (retaspimycin hydrochloride)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Infinity Pharmaceuticals, Inc. | Conditions: Breast Cancer, HER2 Positive Breast Cancer | Phase 2 | Status: TERMINATED